Israeli Stocks Can’t Escape the Drugmakers Drag: ChartBy
Israel’s TA-25 benchmark index is among the five worst-performing global stock exchanges as declines in drugmakers led by Teva Pharmaceutical Industries Ltd. pushed the gauge down the most in two months. Pharmaceutical companies that operate largely outside Israel make up more than a quarter of the TA-25 Index. Teva plunged the most in more than three months after losing a U.S. patent ruling, while Mylan NV, Perrigo Co. and other health companies fell amid questions about the pricing of the EpiPen.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- The U.S. Drops Out of the Top 10 in Innovation Ranking
- Here’s What Trump’s Tariffs on U.S. Imports Are Doing to Markets
- Musk's New Pay Deal Could Make Him the World's Richest Man—If Tesla Succeeds
- Trump's Tariffs on Solar Mark Biggest Blow to Renewables Yet
- This Rare Bear Who Called the Crash Warns Housing Is Too Hot Again